PLATINUM MUSCLE AND BACK PAIN RELIEF TABLET

Ülke: Kanada

Dil: İngilizce

Kaynak: Health Canada

Aktif bileşen:

METHOCARBAMOL; IBUPROFEN

Mevcut itibaren:

VITA HEALTH PRODUCTS INC

ATC kodu:

M03BA53

INN (International Adı):

METHOCARBAMOL, COMBINATIONS EXCL PSYCHOLEPTICS

Doz:

500MG; 200MG

Farmasötik formu:

TABLET

Kompozisyon:

METHOCARBAMOL 500MG; IBUPROFEN 200MG

Uygulama yolu:

ORAL

Paketteki üniteler:

18/27/40/50/80

Reçete türü:

OTC

Terapötik alanı:

OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS

Ürün özeti:

Active ingredient group (AIG) number: 0248961001; AHFS:

Yetkilendirme durumu:

APPROVED

Yetkilendirme tarihi:

2011-01-20

Ürün özellikleri

PRODUCT MONOGRAPH
PLATINUM MUSCLE AND BACK PAIN RELIEF
500 MG METHOCARBAMOL AND 200 MG IBUPROFEN CAPLETS
THERAPEUTIC CLASSIFICATION
MUSCLE RELAXANT / ANALGESIC
VITA HEALTH PRODUCTS INC.
DATE OF PREPARATION:
150 BEGHIN AVENUE,
January 17, 2011
WINNIPEG, MB
CANADA, R2J 3W2
CONTROL NO.: 128349
2
TABLE OF CONTENTS
Page
CLINICAL
PHARMACOLOGY.............................................................................................3
INDICATIONS:
...............................................................................................................6
CONTRAINDICATIONS
.....................................................................................................6
WARNINGS:
.................................................................................................................7
PRECAUTIONS
.............................................................................................................10
DRUG INTERACTIONS
...................................................................................................12
ADVERSE
REACTIONS..................................................................................................13
SYMPTOMS AND TREATMENT OF OVERDOSE
...............................................................15
DOSAGE AND
ADMINISTRATION...................................................................................16
PHARMACEUTICAL
INFORMATION.................................................................................16
COMPOSITION
............................................................................................................19
AVAILABILITY OF DOSAGE
FORMS................................................................................19
INFORMATION FOR THE CONSUMER
.............................................................................20
PHARMACOLOGY
..............................................................................................22
CLINICAL TRIALS
..........................................................................................